Objectives: To compare the extravascular lung water index and other markers of disease severity in patients with acute lung injury vs. patients at risk for development of acute lung injury and to determine their ability to predict progression to acute lung injury in patients at risk.
A cute lung injury (ALI) is a common cause of respiratory failure. An estimated 75,000 patients per year in the United States die of ALI and its associated mor-bidities (1) . Current standard of care is supportive only and there remains a major need for novel therapeutic strategies to treat this illness. As a result, much attention has turned to developing better tools for diagnosis and management of lung injury.
The American-European definition of ALI is based on radiographic and oxygenation criteria, both of which have been shown to be insensitive markers of disease severity and predictors of outcome (2) (3) (4) (5) (6) . The radiographic criteria used to identify patients with ALI are known to have high interobserver variability (5, 6) . Arterial hypoxemia can result from disease processes other than pulmonary edema. Furthermore, the relationship between the ratio of PaO 2 /FIO 2 and the FIO 2 is nonlinear with varying degrees of intrapulmonary shunt (7, 8) and can be confounded by changes in mean airway pressure and positive end-expiratory pressure (9) . Practically speaking, a patient may or may not meet ALI criteria when PaO 2 is measured with varying amounts of positive end-expiratory pres-sure and/or tidal volume, inspiratory times, ventilator mode, or FIO 2 . Therefore, we postulated that current ALI criteria could be insensitive in identifying patients with lung injury and pulmonary edema. As a result, some patients who may benefit from lung-protective ventilation and possibly fluid restriction or depletion may have a delay in treatment and worse outcome.
Markers of severity of illness such as Acute Physiology and Chronic Health Evaluation II (APACHE II) (10) and the Simplified Acute Physiology Score II (SAPS II) (11) have been utilized in predicting mortality in ALI. Pulmonaryspecific markers, such as the Murray Lung Injury Score (12) and physiologic markers such as physiologic dead space fraction (V D /V T ) (13) , oxygenation index (14) , and extravascular lung water index (EVLWi) (4, 15, 16) have been found to be excellent markers of disease severity and predictors of outcome in ALI. However, none of these have been studied for use in predicting progression to ALI in patients at increased risk.
It has been established that ventilatorassociated lung injury significantly worsens lung injury and outcome in those with (17) and without preexisting lung injury (18) . Furthermore early initiation of a low tidal volume ventilator strategy has been found to reduce the frequency of ALI in acutely ill patients with evidence of systemic inflammatory response syndrome (19 -21) . We theorize this is because of ventilator effects on undetected lung injury not meeting American-European Consensus Committee (AECC) criteria for ALI in these patients with systemic inflammatory response syndrome or sepsis (or both). Earlier identification of patients with lung injury who do not yet meet AECC criteria for ALI but who will have progression to it may then alter therapy and improve outcome. Because elevated EVLW has been shown to reflect the degree of lung injury on postmortem examination (22) and is a sensitive marker of disease severity in ALI, we asked if EVLW and other markers of disease severity better-predict progression to ALI in patients at risk (15, 23, 24) . By comparing these metrics in patients with ALI vs. those at risk for development of ALI, we further tested the idea that pulmonary endothelial and epithelial injury are present in those patients who have development of ALI and that EVLW is more sensitive than the current AECC criteria to detect it.
MATERIALS AND METHODS
This was a prospective, observational, single-center study in the adult intensive care units at Oregon Health and Science University conducted over a 20-month period. The protocol was approved by the Institutional Review Board. Intubated patients, at least 18 yrs of age, receiving positive pressure ventilation were eligible if they had ALI or were at risk for development of ALI, severe sepsis, massive aspiration, massive transfusion (receiving 10 units of blood in 24-hr time frame), and/or trauma with long bone fracture and/or pulmonary contusion. Informed consent was obtained from all participants or their surrogates (or both). If subjects lacked capacity to give informed consent, then consent was obtained from the subjects if and when they regained capacity. ALI was defined by the AECC definition (25) , acute onset of bilateral opacities on the chest radiograph, a PaO 2 /FIO 2 ratio Ͻ300 mm Hg, and absence of clinical evidence of left atrial hypertension. Patients who were younger than 18 yrs of age, had a positive pregnancy test, had moderate to severe chronic obstructive lung disease (using home oxygen, using chronic oral glucocorticoid therapy, or with an forced expiratory volume in 1 sec Ͻ50% of predicted), had interstitial lung disease, had undergone lung transplantation, had a contraindication to femoral artery cannulation, had a preexisting non-pulse contour cardiac output femoral artery cannulation, or were moribund (not expected to survive Ͼ24 hrs) were excluded. Patients were enrolled within 48 hrs of meeting the inclusion criteria. Measurements of EVLWi, PaO 2 / FIO 2 , central venous pressure, and V D /V T were performed twice daily over the next 7 days. APACHE II and SAPS II were recorded on day 1. Murray lung injury scores were calculated for the first 5 days of the study. Fluid balance was recorded daily until hospital discharge.
Measurement of Extravascular Lung Water and the Pulmonary Vascular Permeability Index
The transpulmonary thermodilution technique used for the assessment of extravascular lung water has been validated by postmortem gravimetric technique and with the double dilution (thermo-dye) technique (26 -28) , and is being used clinically in the care of critically ill patients (29 -34) . With sensitivity to detect clinically relevant changes in EVLWi, it has been used in both prospective and retrospective studies to discriminate between survivors and nonsurvivors of ALI (15, 16, 23, 35) .
EVLWi was determined using the singleindicator transpulmonary thermodilution technique (PiCCO; Pulsion Medical Systems, Munich, Germany). A 15-mL bolus of 0.9% saline at 5°C was injected via a central venous catheter. The thermodilution curve was recorded with a femoral artery thermistor and was used to calculate the EVLWi as previously described (15) . The boluses were performed in triplicate and an average of the three values was recorded. EVLWi was calculated by dividing the measured lung water by predicted body weight (PBW). PBW was calculated as 50 ϩ 0.91 ϫ (centimeters of height Ϫ 152.4) for males and 45.5 ϩ 0.91 (centimeters of height Ϫ 152.4) for females (36) . Additionally, this technique allows for the determination of the intrathoracic blood volume (ITBV) and the global end-diastolic volume. The global enddiastolic volume index and the ITBV index were determined by dividing these volumes by the body surface area. Pulmonary vascular permeability index (PVPI) was calculated as the EVLW divided by the pulmonary blood volume (PBV) defined as the ITBV Ϫ global end-diastolic volume (PVPI ϭ EVLW/PBV) as a means to normalize EVLW for differences in central blood volumes.
Measurement of Pulmonary Dead Space Fraction
Physiologic dead space fraction (V D /V T ) measurements were performed using a bedside metabolic monitor to determine mean expired carbon dioxide fraction (PECO 2 ) (NiCO; Respironics, Murrysville, PA) after each EV-LWi determination. Because V D /V T is dependent on tidal volume (37), each patient was ventilated at 10 mL/kg PBW for 10 mins, with no bias flow at the time. After ensuring the monitor was appropriately zeroed, the monitor was attached in line with the endotracheal tube. After the PECO 2 reading was stable for 5 mins, an arterial blood gas analysis was performed to obtain PaCO 2 , and the physiologic dead space fraction was calculated using the Bohr-Enghoff equation.
Determination of the EVLW Physiologic Dead Space Index
In an attempt to better-quantify total lung injury-both vascular and alveolar-the product of EVLWi ϫ V D /V T (EVLW physiologic dead space index [EDI]) was calculated and analyzed. We theorized that an index that incorporated markers of primarily endothelial injury as reflected by V D /V T and a marker of endothelial and epithelial injury-EVLWimay have enhanced sensitivity as marker of disease severity. This is a previously untested index developed for this study.
APACHE II and SAPS II scores were calculated using the Web site http://www.sfar.org. Murray lung injury scores were calculated using the Web site http://www.medal.org.
Evaluation of Chest Radiographs
Two critical care attending physicians independently evaluated the chest radiographs in a blinded fashion. They reviewed all the portable antero-posterior chest radiographs for all days that the patient was enrolled in the study. Differences in opinion were settled by discussion between the two physicians while blinded or by the decision of a third blinded physician.
Statistical Analysis
Data are expressed as mean Ϯ SD, frequency (%), or mean (range), unless otherwise noted. Histograms were drawn to determine whether continuous data were normally distributed. Continuous data that were normally distributed was compared using Student t test and non-normally distributed data were compared with the Mann-Whitney U test. Categorical comparisons were made using the chisquare test and Fisher exact test with SPSS 15.0 for Windows (SPSS, Chicago, IL.) A p Ͻ .05 was considered statistically significant. To determine receiver-operating characteristics curves and comparison between different receiver-operating characteristics curves, SPSS software was used. All graphs were created with IgorPro version 5.0.4.8 (WaveMetrics, Lake Oswego, OR).
RESULTS
Thirty-one patients were enrolled in this study. Two patients withdrew before the collection of data as the attending physicians removed the femoral artery catheter. Of the remaining 29 patients, 19 had ALI at some point in the study; 11 had ALI and 18 patients did not at the time of enrollment. Of these 18, 44% (n ϭ 8) had progression to ALI within 5 days of enrollment. There was no significant difference in 28-day mortality between the three groups. Table 1 demonstrates patient characteristics at the time of enrollment. The mean age of the patients was 64 Ϯ 15 yrs (range, 35-86 yrs) and 11 of 18 (61%) were male. The mean APACHE II score was 25 Ϯ 9 (range, 10 -41), and the mean SAPS II was 54 Ϯ 15 (range, 23 -92) . Those with ALI at presentation had higher actual body weight, higher APACHE II and SAPS II scores, lower PaO 2 /FIO 2 , and greater V D /V T than those who had progression to ALI. Actual body weight, APACHE II, SAPS, and static lung compliance did not discriminate between those who had progression to ALI and those who never had development of it. Only EVLWi, the EDI, and the PVPI discriminated between those in whom ALI developed and those who did not have ALI develop as measured on day 1 of the study ( Table 1 ).
The mean EVLWi for patients who had progression to ALI was higher than for those who did not for all 5 days ( Fig. 1 . Among the 11 patients who had ALI at the time of enrollment, seven had EVLWi Ͼ7, but only two had PVPI Ͼ3. Of the 19 patients who had ALI at some point in the study, only two had PVPI Ն3 at the time they first met AECCC criteria for ALI. There were no significant differences in GEDI between the groups. Values are expressed as mean Ϯ SD or frequency (%) unless otherwise noted. a p Ͻ .05 for those who had acute lung injury at enrollment vs. those who had acute lung injury develop; b p Ͻ .05 for those who had acute lung injury develop vs. those who did not; c p Ͻ .05 for those had acute lung injury at enrollment vs. those who did not have acute lung injury develop. Baseline characteristics represent the values obtained on study day 1.
In an attempt to better-quantify total lung injury-both vascular and alveolarthe product of EVLWi ϫ V D /V T (EDI) was calculated and analyzed. Although V D /V T alone did not discriminate between individuals who would have progression to ALI, EDI did. The mean EDI for patients who had progression to ALI was higher than for those who did not for all 5 days (Fig. 1) , reaching statistical significance on day 1 (8.9 Ϯ 4.7 vs. 5.2 Ϯ 1.9; p ϭ .04) and day 2 (9.7 Ϯ 4.2 vs. 5.3 Ϯ 2.2; p ϭ .02).
Receiver-operator characteristic curves were created using the values on the first 2 days to determine the ability of EVLWi, V D /V T , PaO 2 /FIO 2 , and EDI to predict progression to ALI (Figs. 2 and 3) . The areas under the curves (Ϯ SEM) on day 1 were 0.75 Ϯ 0.13, 0.57 Ϯ 0.14, 0.71 Ϯ 0.13, and 0.77 Ϯ 0.12 for EVLWi, V D /V T , PaO 2 /FIO 2 , and EDI, respectively. On the second day, the areas under the curves (Ϯ SEM) were 0.82 Ϯ .11, 0.65 Ϯ 0.14, 0.65 Ϯ 0.14, and 0.85 Ϯ 0.09 for EVLWi, V D /V T , PaO 2 /FIO 2 , and EDI, respectively. An EVLWi cutoff value of 11.5 mL/kg PBW on day 1 predicted progression to ALI on the first day with 57% sensitivity and 100% specificity. An EVLWi Ͼ10 mL/kg PBW predicted progression to ALI with sensitivity of 63%, specificity of 88%, positive predictive value of 83%, and negative predictive value of 70%. The predictive value of EVLWi improved on the second day, with a value of 15.3 mL/kg PBW predicting progression to ALI with 63% sensitivity and 100% specificity.
DISCUSSION
This study has shown that elevated EVLWi is a common feature of early ALI and that it predicts progression to ALI in patients at increased risk for development of ALI. EVLWi predicts progression to ALI in patients at risk for development of ALI better than all markers of disease severity tested. Furthermore, EVLWi predicted progression to ALI 2.6 days before these patients met AECC criteria for it. EVLWi has previously been shown to be a sensitive marker of disease severity in ALI, and has been shown to be associated with the degree of endothelial and epithelial injury and excess lung weight on postmortem examination (15, 16, 23, 35) in patients with pulmonary edema. Mean EVLWi was as elevated in those who had progression to ALI but did not yet meet AECC criteria as in those with ALI on the first day of the study. This supports the idea that EVLWi reflected injury that was present on the first day in those who had development of ALI, and that EVLWi is more sensitive than the current AECC criteria to detect it. These 2.6 Ϯ 0.3 days may represent missed opportunity for therapeutic intervention such as initiation of lung-protective ventilation and improvement of outcome.
Other Markers of Disease Severity Fail to Predict Progression to ALI
Physiologic dead space fraction has been found to predict mortality in ALI (13), but we have shown that it does not predict progression to ALI in those patients at risk. A PVPI Ն3 has been found to discriminate between hydrostatic and nonhydrostatic pulmonary edema with 85% sensitivity and 100% specificity (38) . However, we have found that this value does not discriminate between those with ALI and those without ALI. Only two of our patients with ALI had a PVPI Ն3. Therefore, a PVPI Ն3 does not appear to be useful in defining ALI. It is unclear if the PVPI should be used to predict progression to ALI, above and beyond simply measuring the EVLWi. The PVPI is not a measure of vascular permeability, but rather an attempt to normalize lung water to differences in PBV (PVPI ϭ EVLW/PBV). Because pulmonary blood volume was not significantly different among the various subgroups, it is unclear if the PVPI would have better-predicted progression to ALI had there been differences. Because there was no difference in PBV, we would expect the PVPI to have a similar predictive value for progression to ALI as EVLWi, as we found. Further studies are needed that include patients with varying PBV to more fully examine this.
The PaO 2 /FIO 2 did not discriminate between patients with progression to ALI and those who did not have progression to ALI. This is not surprising because the PaO 2 /FIO 2 is confounded by variations in FIO 2 , ventilator mode, mean airway pressure, and positive end-expiratory pressure, and it has not been found to be a sensitive indicator of lung injury or a reliable predicator of outcome in numerous studies (15, 39, 40) . The Murray lung injury score did discriminate between those who had progression to ALI and those who did not. However, this did not reach statistical significance until day 2. Furthermore, treatment strategies utilizing EVLWi as a hemodynamic and preload metric have been previously shown to improve outcome in this disease (41, 42) . It is unlikely the lung injury score could be similarly incorporated into such a treatment strategy.
The EDI
Increased EVLWi is believed to result from changes in permeability and intravascular fluid extravasation, epithelial injury, and alveolar fluid clearance resulting in excess lung water. An increase in V D /V T in acute respiratory distress syndrome is believed to be caused, in part, by endothelial injury, platelet activation, and microthrombus formation. This injury tends to occur later in the disease process. We postulated that V D /V T and EVLWi might then be combined to give a better indicator of overall lung injuryespecially later in the disease-when EV-LWi alone may lose sensitivity. We examined this by testing the ability of V D /V T to discriminate between those who had progression to ALI and those who did not during the first 5 days of the study. We combined EVLWi and V D /V T as a simple product (EVLWi ϫ V D /V T ) to give equal weight to both measures. We then compared V D /V T , PaO 2 /FIO 2 , EVLWi, and EDI in terms of their abilities to discriminate progression to ALI in those at risk in a receiver-operator characteristic curve. The area under the curve was essentially the same as EVLWi on day 1 but was greater by day 2 (Fig. 3) . In this preliminary study, the small number of patients in each of our subgroups group impairs statistical comparison of these curves, but examination of the same data over the course of the first 3 days (Fig. 1 ) illustrated excellent separation of those who had progression to ALI vs. those who did not using the EDI. Of note, there were no significant differences in V D /V T between those who had progression to ALI vs. those who did not in our study. Larger studies are needed to examine if differences in V D /V T occur among the various subgroups at risk for ALI and whether this would increase the trend for improved detection of injury, disease severity, and prediction of ALI using the EDI as compared to EVLWi alone.
The American-European Definition of ALI Is Insensitive for Detecting Lung Injury
Among the patients who did not meet clinical criteria for ALI at the time of enrollment who then had progression to ALI, two of the eight had chest radiographs that were consistent with ALI on day 1, but the PaO 2 /FIO 2 were Ͼ300 at that time ( Table 2 ). The remaining six patients had development of pulmonary edema on chest radiograph on day 2. Three of these patients did not meet PaO 2 / FIO 2 criteria until day 3; one did not meet PaO 2 /FIO 2 criteria until day 4. In patients who went on have ALI develop, EVLWi was elevated on day 1 and remained elevated an average of 2.6 days before the patients met consensus criteria for ALI. This would seem to indicate that lung injury was present at presentation in those with progression to ALI and that EVLWi is a sensitive indicator of that injury. Whether this represents a therapeutic window in which to improve outcome will require a large interventional trial to discern. However, it is clear from this and preceding studies that EVLWi is a sensitive marker of lung injury, predicts progression to ALI better, and thus may be a more sensitive marker of lung injury than criteria presently used in our definition of ALI. Therefore, perhaps we should ask, do we need to change the definition of ALI and should we consider including measured EVLWi?
The amount of EVLWi results from a dynamic balance between factors causing fluid to enter the lung vs. factors that carry the fluid away. Changes in vascular permeability, hydrostatic pressure, oncotic pressure, white blood cell emigration and inflammation, alveolar epithelial injury and alveolar fluid clearance, disruption in the architecture of the interstitial matrix, and lymph clearance all contribute to changes in EVLWi. Changes in all of these can and do occur in ALI; it is not surprising, then, that in the appropriate clinical setting elevated EVLWi has been found to be a highly sensitive marker of lung injury and predicts progression to and outcome in ALI.
It is our opinion that the AECC criteria should be revisited, that more mechanistic criteria should be incorporated in the definition, and that EVLW may have a role to play. People with heart failure can have ALI develop. Sepsis-related ALI can result in cardiomyopathy and acute heart failure. The two conditions are not mutually exclusive. Furthermore, the PaO 2 / FIO 2 ratio is nonlinear at a FIO 2 Ͼ0.6 and is confounded by changes in positive endexpiratory pressure and mean airway pressure.
This study has shown that elevated EVLWi is a common feature of ALI, that it detects the presence of lung injury early, and that it predicts progression to ALI approximately 2.6 days before current criteria are met. Our study suggests that this is because EVLWi is a more sensitive indicator of the presence of lung injury. Given these findings, bedside determination of EVLWi may have a role in helping to better-define ALI. EVLWi can be elevated (EVLWi Ͼ7 mL/kg) in patients who may not have severe enough lung injury to warrant lung-protective ventilation and other therapeutic interventions for ALI. We propose using that value that we have found to best predict progression to ALI, an EVLWi Ͼ10 mL/kg, in a definition that also includes consideration of the clinical setting.
The late Dr. Daniel Schuster has said, "The diagnosis of acute respiratory distress syndrome (ideally) should not be a diagnosis of exclusion but instead depend on some direct measure of lung injury." He thought measured vascular permeability might be the desired direct measure of injury. Since that time, we and others have found that bedside determination of EVLWi is a much simpler measurement to perform and it is a highly sensitive marker of injury, disease severity, and predictor of outcome. The findings of our current study need to be confirmed in larger studies before we may consider using EVLWi in a new definition for ALI. But if confirmed, what would such a definition of ALI that incorporates EVLWi look like? Here, we present one idea that borrows heavily from the approach of Dr. Shuster while using EVLWi as the direct measure of lung injury: an appropriate clinical setting-sepsis, severe trauma, pneumonia, massive transfusion, and others; bilateral chest radiograph opacities consistent with pulmonary edema; and EVLWi Ͼ10 mL/kg.
We include the chest radiograph because our data show that all patients who had progression to ALI had chest radiograph findings consistent with ALI no later than day 2. It was the PaO 2 /FIO 2 that most delayed meeting criteria for ALI.
Aggressive Fluid Resuscitation May Be Detrimental
Although there was no statistically significant difference in fluid balance between individuals who had ALI developed and those who did not, there was a trend toward higher fluid balance in the group in whom ALI developed. In fact, the daily fluid balance was 2-4 L greater in the group in whom ALI developed vs. those who did not. It is unlikely that the individuals who had ALI develop received more fluid because they were "sicker," because the APACHE II and SAPS scores were not different between the two groups. This, perhaps, suggests that using a fluid-restrictive strategy earlier may have been beneficial.
Limitations
This preliminary study was limited by small numbers of patients in the subgroups. Thus, we could not determine whether elevated EVLWi is an independent risk factor for progression to ALI in all patients at risk for development of it, and larger studies are needed to discern this. Despite being blinded to the study results, there was large interobserver variability in chest radiograph determinations, and this may have influenced the study results. However, the large interobserver variability is in line with those previously reported and with clinical practice.
CONCLUSIONS
Elevated EVLWi is a common feature of early ALI and discriminates between those with ALI and those without. EVLWi predicts progression to ALI in patients at risk for development of it 2.6 Ϯ 0.3 days before the patients met AECC criteria for it. EVLWi was similarly elevated in those 55, M  2  3  3  65, M  1  2  2  86, M  1  2  2  59, F  2  3  3  37, F  2  1  2  72, F  2  2  2  64, F  2  3  3  50, F  2  4  4 F, female; M, male.
with ALI as in those who had progression to it, but significantly less in those that never had it develop, supporting the idea that significant lung injury was present in those who had development of ALI and that EVLWi is more sensitive than the current AECC criteria in detecting it. These 2.6 Ϯ 0.3 days may then represent missed opportunity for therapeutic intervention to limit ventilator-associated lung injury and improve outcome. There is a trend toward greater predictive value in identifying patients at risk for development of ALI using a new index, the EDI (V D /V T ϫ EVLWi). Larger studies are needed to determine whether elevated EVLWi and EDI are independent risk factors for progression to ALI in all patients at risk for development of it and whether initiation of lung-protective ventilator strategies or goal-directed fluid management (or both) based on early changes in EVLWi or EDI improves outcome.
